Apertura Gene Therapy Advances NPC1 Gene Therapy Research
NEW YORK | July 9, 2026 Apertura Gene Therapy, a biotechnology company developing next-generation adeno-associated virus (AAV) capsids for...
Preclinical Research
Advertisement
IDEAYA and Roche Advance Targeted Therapy for PDAC
SOUTH SAN FRANCISCO, California, USA, June 3, 2026 IDEAYA Biosciences and Roche have entered into a strategic clinical collaboration...
Antengene Presents First ATG-207 Autoimmune Disease Data at EULAR 2026
SHANGHAI, China, June 3, 2026 Antengene has announced the first preclinical data for ATG-207, its investigational αCD3-TGF-β bifunctional fusion...
Vector Science & Therapeutics Files Patent for Platform
MEQUON, Wis., May 1, 2026 Vector Science & Therapeutics, Inc. has announced the filing of a provisional patent application...
Interna, Daiichi Sankyo Partner on Drug Delivery Tech
PETACH TIKVA, Israel, April 16, 2026 Interna Therapeutics has announced a strategic research collaboration with Daiichi Sankyo to advance...
Advertisements
Insilico Medicine Advances ISM6200 for Cancer Therapy
HONG KONG | April 10, 2026 Insilico Medicine has announced the nomination of ISM6200, a potential best-in-class selective NR3C1...
Insilico, Lilly Sign $2.75B AI Drug Discovery Deal
Hong Kong | March 30, 2026 Strategic AI Collaboration to Accelerate Drug Discovery Insilico Medicine has announced a major...
AI Drug Discovery Deal Expands CNS Pipeline Value
Hong Kong | March 30, 2026 AI Collaboration Accelerates CNS Drug Discovery Insilico Medicine and Tenacia Biotechnology have announced...
Junevity Study Reveals Single-Target Control of Cellular Aging
BOSTON, Massachusetts — January 12, 2026 — Junevity has announced the publication of its first peer-reviewed scientific study demonstrating...
NAMSA Acquires Labcorp Device Testing Assets to Expand MedTech
Toledo, Ohio — January 8, 2026 — NAMSA, a global leader in medical device testing, clinical research, and regulatory...
Advertisement
